ARGs are associated with the development and prognosis of various cancers, including ovarian cancer (Qian et al., 2023), thyroid cancer (Tang et al., 2024), and renal cell carcinoma (He et al., 2023). Here, SERPINA2 is linked to hereditary clear cell renal cell carcinoma.